药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sulfamethazine
Plantago seed
The risk or severity of adverse effects can be increased when Plantago seed is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Carboxymethylcellulose
The risk or severity of adverse effects can be increased when Carboxymethylcellulose is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Sodium sulfate
The risk or severity of adverse effects can be increased when Sodium sulfate is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Polycarbophil
The risk or severity of adverse effects can be increased when Polycarbophil is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Picosulfuric acid
The risk or severity of adverse effects can be increased when Picosulfuric acid is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Bisacodyl
The risk or severity of adverse effects can be increased when Bisacodyl is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Oxyphenisatin
The risk or severity of adverse effects can be increased when Oxyphenisatin is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Dantron
The risk or severity of adverse effects can be increased when Dantron is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Sorbitol
The risk or severity of adverse effects can be increased when Sorbitol is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Alcuronium
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Alcuronium.
Sulfamethazine
Gallamine
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Gallamine.
Sulfamethazine
Atracurium
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Atracurium.
Sulfamethazine
Hexamethonium
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Hexamethonium.
Sulfamethazine
Gantacurium
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Gantacurium.
Sulfamethazine
Homatropine
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Homatropine.
Sulfamethazine
Magnesium trisilicate
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Magnesium trisilicate.
Sulfamethazine
Magnesium peroxide
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Magnesium peroxide.
Sulfamethazine
Magnesium hydroxide
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Magnesium hydroxide.
Sulfamethazine
Aluminium phosphate
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Aluminium phosphate.
Sulfamethazine
Calcium silicate
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Calcium silicate.